Reducing Stigma Through a Mental Health Art Exhibition and Its Printed Brochure

NCT06366373 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2025-01-29

No results posted yet for this study

Summary

Mental health art exhibitions, as an intervention strategy integrating artistic expression and social contact, have the potential to positively impact the elimination of stigma and discrimination associated with mental health problems. Based on a two-phase experimental design, this study aims to evaluate the effect of a real-world mental health art exhibition (Phase One) and its printed brochure (Phase Two) on stigma/discrimination and related outcomes, such as mental health literacy. The evaluation will encompass three categories of people: those with lived experience of mental disorders, family members and friends of those with lived experience, and the general public. Qualitative methods, such as in-depth interviews, will also be used for the evaluation.

Conditions

  • Mental Health Issue

Interventions

OTHER

A mental health art exhibition

The specific intervention measure is the Second Mental Health Art Science Exhibition scheduled to take place in Wuhan, China from April 27 to May 27, 2024. Organized by "Qixi Charity", an NGO led by individuals with lived experience of mental disorders, as well as their family members and friends, the exhibition will feature offline artworks created by these individuals and other contributors. The exhibited artworks aim to reflect the diverse dimensions of mental health and ill-health.

OTHER

printed or online education materials

The specific intervention measure is to provide printed or online education materials within the first month after the baseline survey

Sponsors & Collaborators

  • Central South University

    collaborator OTHER
  • Qixi Charity

    collaborator UNKNOWN
  • Hunan University

    lead OTHER

Principal Investigators

  • Wei Zhou, Ph.D. · Hunan University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-12
Primary Completion
2025-05-31
Completion
2025-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06366373 on ClinicalTrials.gov